• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anacor Pharmaceuticals Inc

+ Add to Watchlist


24.624 EUR 2.270 8.44%

As of 15:14:37 ET on 12/23/2014.

Company Profile for Anacor Pharmaceuticals Inc (44A)

Anacor Pharmaceuticals Inc. is a biopharmaceutical company developing small-molecule therapeutics derived from our boron chemistry platform. The Company is focused on developing topical applications to treat fungal, bacterial and inflammatory diseases.

Contact Information

Anacor Pharmaceuticals Inc

1020 East Meadow Circle
Palo Alto, CA 94303-4230
United States
Phone: 1-650-543-7500
Fax: 1-650-543-7660

Key Executives for Anacor Pharmaceuticals Inc (44A)

Paul L BernsPresident/CEOVincent P IppolitoExec VP/Chief Commercial Ofcr
Geoffrey M ParkerSenior VP/CFOKirk R MaplesSenior VP:Program Management
Sanjay ChandaVP/Interim Head:Drug DevLee T ZaneVP:Clinical Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil